Association between severe adverse event management and overall survival in patients treated with immune checkpoint inhibitor with advanced non-small-cell lung cancer

被引：0
|
作者：
Naidoo, Jarushka
Johnson, Douglas Buckner
Doran, Charlotte
Wang, Yuexi
Zhang, Yan
Le, Trong Kim
Hopson, Sari
Dreyfus, Brian
Lal, Lincy S.
Vyas, Charmy
Goldstein, Shay
Izadi, Zara
机构：
[1] Beaumont RCSI Canc Ctr, Dublin, Ireland
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] ConcertAI, Cambridge, MA USA
[4] Bristol Myers Squibb, Princeton, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6604
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab
    Toi, Yukihiro
    Sugawara, Shunichi
    Kawashima, Yosuke
    Aiba, Tomoiki
    Kawana, Sachiko
    Saito, Ryohei
    Tsurumi, Kyoji
    Suzuki, Kana
    Shimizu, Hisashi
    Sugisaka, Jun
    Ono, Hirotaka
    Domeki, Yutaka
    Terayama, Keisuke
    Nakamura, Atsushi
    Yamanda, Shinsuke
    Kimura, Yuichiro
    Honda, Yoshihiro
    ONCOLOGIST, 2018, 23 (11): : 1358 - 1365
  • [22] Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement
    Oya, Yuko
    Kuroda, Hiroaki
    Nakada, Takeo
    Takahashi, Yusuke
    Sakakura, Noriaki
    Hida, Toyoaki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (07)
  • [23] Efficacy of immune checkpoint inhibitor monotherapy in elderly patients with non-small-cell lung cancer
    Kubo, Toshio
    Ichihara, Eiki
    Harada, Daijiro
    Inoue, Koji
    Fujiwara, Keiichi
    Hosokawa, Sinobu
    Kishino, Daizo
    Kawai, Haruyuki
    Ochi, Nobuaki
    Oda, Naohiro
    Hara, Naofumi
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    RESPIRATORY INVESTIGATION, 2023, 61 (05) : 643 - 650
  • [24] Efficacy of immune checkpoint inhibitor monotherapy for patients with massive non-small-cell lung cancer
    Hakozaki, Taiki
    Hosomi, Yukio
    Kitadai, Rui
    Kitagawa, Shingo
    Okuma, Yusuke
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (11) : 2957 - 2966
  • [25] Efficacy of Immune Checkpoint Inhibitor Monotherapy for Patients With Massive Non-Small-Cell Lung Cancer
    Hakozaki, T.
    Kitadai, R.
    Kitagawa, S.
    Hosomi, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S520 - S521
  • [26] Discontinuation of Immune Checkpoint Inhibitor and Survival in Patients With Non-small-cell Lung Cancer Without a Driver Gene Mutation
    Hattori, Sou
    Okauchi, Shinichiro
    Sasatani, Yuika
    Ohara, Gen
    Miyazaki, Kunihiko
    Sato, Shinya
    Kodama, Takahide
    Shiozawa, Toshihiro
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    ANTICANCER RESEARCH, 2022, 42 (09) : 4589 - 4595
  • [27] Efficacy of immune checkpoint inhibitor monotherapy for patients with massive non-small-cell lung cancer
    Taiki Hakozaki
    Yukio Hosomi
    Rui Kitadai
    Shingo Kitagawa
    Yusuke Okuma
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2957 - 2966
  • [28] The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors
    Oh, Michael S.
    Guzner, Alex
    Wainwright, Derek A.
    Mohindra, Nisha A.
    Chae, Young K.
    Behdad, Amir
    Villaflor, Victoria M.
    CLINICAL LUNG CANCER, 2021, 22 (01) : E57 - E62
  • [29] Immune Checkpoint Inhibitors for Patients With Advanced Non-Small-Cell Lung Cancer: A Systematic Review
    Ellis, Peter M.
    Vella, Emily T.
    Ung, Yee C.
    CLINICAL LUNG CANCER, 2017, 18 (05) : 444 - U75
  • [30] Association between body mass index and survival outcomes for patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis
    Sun, Yanxin
    Sun, Yuping
    Li, Juan
    Gao, Aiqin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345